v3.25.1
STOCKHOLDERS’ EQUITY (DEFICIT)
 3 Months Ended
Mar. 31, 2025
STOCKHOLDERS' DEFICIT:  
STOCKHOLDERS’ EQUITY (DEFICIT)

NOTE 14 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

Preferred Stock

 

In accordance with the Company’s bylaws, the Company has authorized a total of 2,000,000 shares of preferred stock, par value $0.01 per share, for all classes. As of March 31, 2025 and 2024 respectively, there were 88,335 and 88,335 total preferred shares issued and outstanding for all classes.

 

Common Stock

 

In accordance with the Company’s bylaws, the Company has authorized a total of 20,000,000,000 shares of common stock, par value $0.0001 per share. As of March 31, 2025 and 2024, there were 12,186,976,200 and 8,330,852,145 common shares issued, respectively.

 

2024 Transactions

 

On November 6, 2024 the Company entered into an Amendment to the 2023 Equity Financing Agreement with GHS, to which GHS agreed to Purchase $30,000,000 in shares of our Common Stock over the course of 12 months at 92% of the current market price.

 

The below table of puts from 1/03/2025 through 3/27/2025 were made by the Company under the 2024 EFA during 2025:

                
Date of Put  Number of Common Shares Issued  Total Proceeds, Net of Discounts   Effective Price per Share  Net Proceeds 
               
1/3/2025  36,640,675   23,450   $0.000640   20,783 
1/13/2025  51,215,454   32,778   $0.000640   29,458 
1/22/2025  79,061,625   50,619   $0.000640   46,050 
1/30/2025  139,008,500   55,603   $0.000400   50,686 
2/7/2025  124,797,875   49,786   $0.000399   45,276 
2/18/2025  131,445,657   42,063   $0.000320   38,093 
2/27/2025  142,074,500   34,098   $0.000240   30,686 
3/10/2025  132,699,709   31,848   $0.000240   28,594 
3/18/2025  224,563,917   53,895   $0.000240   40,098 
3/27/2025  203,844,344   65,230   $0.000320   59,639 

 

The RRA provides that we shall (i) use our best efforts to file with the SEC a Registration Statement within 45 days of the date of the GHS Registration Rights Agreement; and (ii) have the Registration Statement declared effective by the SEC within 30 days after the date the GHS Registration Statement is filed with the SEC, but in no event more than 90 days after the GHS Registration Statement is filed.

  

Stock Options

 

As of March 31, 2025 and 2024, the Company had no outstanding stock options.